MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Germ Cell Cancer

(UMLS:C0740345)

UMLS ID:: C0740345
MeSH ID:: D009373

Classification:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.465

Synonym(s)

Germ Cell Cancer

Germ cell cancer

cancer cells germ

germ cell cancer

germ cell cancers

Associated Drug(s)

	Name	Number of Reports	Data Source
1	Clozapine	FAERS: 2 Canada Vigilance: 1	Canada Vigilance US FAERS
2	Lopinavir	FAERS: 1	US FAERS
3	eltrombopag	FAERS: 1	US FAERS
4	trametinib	FAERS: 1	US FAERS
5	Deamino Arginine Vasopressin		OFFSIDES
6	Estrogens, Conjugated (USP)		OFFSIDES
7	Etoposide		OFFSIDES
8	Hydrocortisone		OFFSIDES
9	Medroxyprogesterone Acetate		OFFSIDES
10	Medroxyprogesterone		OFFSIDES
11	Methocarbamol		OFFSIDES
12	Ribavirin		OFFSIDES

Similar ADE(s)

	Name	Semantic Similarity
1	leukemia	42.9%
2	Neoplasms, Glandular and Epithelial	42.9%
3	Carcinosarcoma	37.1%
4	Hemangiosarcoma	37.1%
5	lymphangiosarcoma	37.1%
6	Basal cell carcinoma	33.3%
7	Carcinoma, Papillary	33.3%
8	Squamous cell carcinoma	33.3%
9	Chondrosarcoma	33.3%
10	Cystadenoma	33.3%
11	leiomyosarcoma	33.3%
12	liposarcoma	33.3%
13	Mesothelioma	33.3%
14	synovial sarcoma	33.3%
15	Angiomyolipoma	33.3%
16	Clear Cell Sarcoma of Soft Tissue	33.3%
17	Alveolar Soft Part Sarcoma	33.3%
18	Sarcoma, Myeloid	33.3%
19	Carcinoma, Basal Cell	33.3%
20	Cystadenocarcinoma	31.5%
21	Fibrosarcoma	31.5%
22	Osteosarcoma	31.5%
23	Mucoepidermoid Carcinoma	31.5%
24	Adenoma	31%
25	Ameloblastoma	31%
26	Angiokeratoma	31%
27	Carcinoma	31%
28	Hemangioma	31%
29	hemangiopericytoma	31%
30	Lymphangioma	31%
31	Mesenchymoma	31%
32	Nevus	31%
33	Hepatoblastoma	31%
34	Mixed Tumor, Mullerian	31%
35	Angiofibroma	31%
36	Sarcoma	31%
37	Epithelioma	31%
38	Carcinoma 256, Walker	30.8%
39	Adenofibroma	30.6%
40	Fibroadenoma	30.6%
41	Malignant Fibrous Histiocytoma	30.6%
42	Bowen's Disease	29.7%
43	Rhabdomyosarcoma	29.7%
44	Giant Cell Tumor of Bone	29.7%
45	Dermatofibrosarcoma	28.8%
46	Dermatofibrosarcoma Protuberans	28.8%
47	Histiocytic Disorders, Malignant	27.9%
48	Alveolar rhabdomyosarcoma	27.9%
49	Leukemia, Plasma Cell	27.5%
50	Neoplasms, Neuroepithelial	27.5%
51	Gliomatosis cerebri	27.5%
52	Meningioma	26.9%
53	Carcinoma, Ehrlich Tumor	26.4%
54	Carcinoma, Lewis Lung	26.4%
55	melanoma	26%
56	Adenocarcinoma	25.4%
57	Carcinoma in Situ	25.4%
58	Carcinoma, Transitional Cell	25.4%
59	Phyllodes Tumor	25.4%
60	Hemangioendothelioma	25.4%
61	Lipoma	25.4%
62	Myoma	25.4%
63	Myxoma	25.4%
64	Neuroma	25.4%
65	Papilloma	25.4%
66	Pseudomyxoma Peritonei	25.4%
67	Papillomatosis	25.4%
68	Angiolipoma	25.4%
69	Myelolipoma	25.4%
70	Neoplasms, Bone Tissue	25.4%
71	Neoplasms, Fibrous Tissue	25.4%
72	Smooth Muscle Tumor	25.4%
73	Adenomatosis, Pulmonary	25.4%
74	Adenomatous Polyps	25.4%
75	Carcinoma, Large Cell	25.4%
76	Carcinoma, Small Cell	25.4%
77	Desmoplastic Small Round Cell Tumor	25.4%
78	Chondroma	25.4%
79	Enchondroma	25.4%
80	Medulloblastoma	24.1%
81	Composite Lymphoma	24%
82	Leukemia L1210	23.6%
83	Leukemia P388	23.6%
84	Acanthoma	23.6%
85	Adenoma, Acidophil	23.4%
86	Ganglioneuroma	23.4%
87	Glioma	23.4%
88	Malignant Glioma	23.4%
89	Hamartoma	23.1%
90	Neoplasms, Hormone-Dependent	23.1%
91	Neoplasms, Multiple Primary	23.1%
92	Paraneoplastic Syndromes	23.1%
93	Precancerous Conditions	23.1%
94	Neoplasms, Second Primary	23.1%
95	Carcinoma, Lobular	22.8%
96	Adenoid Cystic Carcinoma	22.7%
97	fibroma	22.7%
98	Fibromatosis	22.7%
99	Osteoblastoma	22.7%
100	Osteoma	22.7%
101	Rhabdomyoma	22.7%
102	Chondromatosis	22.7%
103	Adenocarcinoma, Clear Cell	22.7%
104	Cholangiocarcinoma	22.7%
105	Cervical Intraepithelial Neoplasia	22.7%
106	Hemangioblastoma	22.7%
107	Lymphoma, Extranodal NK-T-Cell	22.7%
108	Hutchinson's Melanotic Freckle	22.7%
109	Melanoma, Amelanotic	22.7%
110	Leukemia, Experimental	22.2%
111	Carcinoid Tumor	22%
112	Neurilemmoma	22%
113	Sarcoma 180	21.8%
114	Neurofibrosarcoma	21.4%
115	Astrocytoma	21.3%
116	Ependymoma	21.3%
117	oligodendroglioma	21.3%
118	Ganglioglioma	21.3%
119	gliosarcoma	21.3%
120	Anaplastic astrocytoma	21.3%
121	Anaplastic Oligodendroglioma	21.3%
122	Fibromatosis, Aggressive	21.3%
123	Fibromatosis, Abdominal	21.3%
124	Klatskin Tumor	21.3%
125	Lymphoma	20.7%
126	Malignant Carcinoid Syndrome	20.7%
127	Endometrial Stromal Sarcoma	20.6%
128	Plasmacytoma	20.5%
129	Neuroectodermal Tumors	20.5%
130	Glioblastoma	20.3%
131	Neuroblastoma	20.3%
132	Glioblastoma Multiforme	20.3%
133	Malignant histiocytosis	20.2%
134	Histiocytic sarcoma	20.2%
135	Ganglioneuroblastoma	19.8%
136	Lymphangioleiomyomatosis	19.7%
137	Melanoma, Experimental	19.7%
138	Sarcoma, Experimental	19.5%
139	Thymoma	19.3%
140	Leukemia, Radiation-Induced	17.9%
141	Craniopharyngioma	16.7%
142	Leukemia, Myelomonocytic, Chronic	16.7%
143	Neuroectodermal Tumor, Melanotic	16.7%
144	Neuroendocrine Tumors	16.7%
145	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	16.7%
146	Carcinoid Heart Disease	16.3%
147	Mastocytoma	15.1%
148	Cyst	15%
149	Hodgkin Disease	15%
150	Lymphoma, Non-Hodgkin	15%
151	Neoplastic Processes	15%
152	Neoplastic Syndromes, Hereditary	15%
153	Pregnancy Complications, Neoplastic	15%
154	Mastocytosis, Systemic	14.9%
155	Carcinoma, Pancreatic Ductal	14.9%
156	Leukemia, Myeloid, Chronic-Phase	14.8%
157	Paraganglioma	14.8%
158	Neoplasms, Experimental	14.6%
159	Abdominal Neoplasms	14.3%
160	Erythroplasia	14.3%
161	Follicular cyst	14.3%
162	Head and Neck Neoplasms	14.3%
163	Mucocele	14.3%
164	Pilonidal Cyst	14.3%
165	Soft Tissue Neoplasms	14.3%
166	Thoracic Neoplasms	14.3%
167	Thyroglossal Cyst	14.3%
168	Synovial Cyst	14.3%
169	Aberrant Crypt Foci	14.3%
170	Lymphomatoid Granulomatosis	14.2%
171	Pheochromocytoma	13.9%
172	Retinoblastoma	13.9%
173	Hepatocellular Adenoma	13.3%
174	Basal Cell Nevus Syndrome	13.1%
175	Choriocarcinoma	12.9%
176	Mastocytosis	12.8%
177	Sturge-Weber Syndrome	12.8%
178	Multiple Endocrine Neoplasia	12.8%
179	Gastrointestinal Stromal Tumors	12.6%
180	Hemangioma, Cavernous	12.5%
181	Leukemia, T-Cell	12.4%
182	Leukemia, B-Cell	12.4%
183	neurofibroma	12.3%
184	Lymphoma, Follicular	12.3%
185	T-Cell Lymphoma	12.3%
186	Mantle cell lymphoma	12.3%
187	Paraneoplastic Encephalomyelitis	12.3%
188	Primary amyloidosis	12.1%
189	Mammary Neoplasms, Experimental	12%
190	Acoustic Neuroma	11.5%
191	Nephroblastoma	11.2%
192	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	11%
193	Leukemia, Large Granular Lymphocytic	11%
194	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	11%
195	Prolactinoma	11%
196	Growth Hormone-Secreting Pituitary Adenoma	11%
197	Lymphoma, T-Cell, Cutaneous	11%
198	Lymphoma, AIDS-Related	11%
199	Enteropathy-Associated T-Cell Lymphoma	11%
200	Primary Effusion Lymphoma	11%
201	Dupuytren Contracture	10.8%
202	Neoplasms, Radiation-Induced	10.8%
203	Urticaria Pigmentosa	10.6%
204	Mesoblastic Nephroma	10.5%
205	insulinoma	10.4%
206	Retroperitoneal Neoplasms	10.3%
207	Mycosis Fungoides	10.3%
208	Lymphomatoid Papulosis	10.3%
209	Plasmablastic lymphoma	10.3%
210	Optic Nerve Glioma	10.3%
211	Gastrinoma	10.1%
212	Glucagonoma	10.1%
213	Digestive System Neoplasms	10%
214	Endocrine Gland Neoplasms	10%
215	Eye Neoplasms	10%
216	Nervous System Neoplasms	10%
217	Adrenocortical carcinoma	9.8%
218	Bone neoplasms	9.5%
219	Leukoplakia	9.5%
220	Lymphocele	9.5%
221	Pancreatic Cyst	9.5%
222	Skin Neoplasms	9.5%
223	Hematologic Neoplasms	9.5%
224	Multiple Endocrine Neoplasia Type 1	9.4%
225	granulosa cell tumor	9.3%
226	Carcinoma, Ovarian Epithelial	9.3%
227	Barrett Esophagus	9.3%
228	Breast Cyst	9.3%
229	Actinic keratosis	9.3%
230	Mediastinal Cyst	9.3%
231	Neoplasm Invasiveness	9.3%
232	Neoplasm Metastasis	9.3%
233	Neoplasm Recurrence, Local	9.3%
234	Parovarian Cyst	9.3%
235	Pericardial Cyst	9.3%
236	Splenic Neoplasms	9.3%
237	Thymic Cyst	9.3%
238	Carcinogenesis	9.3%
239	Myxoid cyst	9.3%
240	Metastasis	9.3%
241	Dermoid Cyst	9.2%
242	Leydig Cell Tumor	9%
243	Vipoma	8.8%
244	Waldenstrom Macroglobulinemia	8.6%
245	Multiple Myeloma	8.6%
246	Adenomatous Polyposis Coli	8.4%
247	Renal Cell Carcinoma	8.3%
248	Parathyroid Neoplasms	8.3%
249	Peritoneal Neoplasms	8.3%
250	Thyroid Neoplasm	8.3%
251	Thyroid carcinoma	8.3%
252	Papillary Renal Cell Carcinoma	8.3%
253	Tuberous Sclerosis	8.2%
254	Carcinoma, Endometrioid	8.2%
255	Nasopharyngeal carcinoma	7.8%
256	Tracheal Neoplasms	7.6%
257	Leukoplakia, Oral	7.4%
258	Burkitt Lymphoma	7.3%
259	Paraneoplastic Cerebellar Degeneration	7.3%
260	Liver Neoplasms, Experimental	7.3%
261	Mouth Neoplasms	7%
262	Pancreatic Neoplasm	7%
263	Central Nervous System Neoplasms	7%
264	Vascular Neoplasms	7%
265	Thymus Neoplasms	7%
266	Sezary Syndrome	6.9%
267	Trophoblastic Neoplasms	6.9%
268	Genital Neoplasms, Female	6.8%
269	Pancreatic Pseudocyst	6.8%
270	Corpus Luteum Cyst	6.8%
271	Ovarian Cysts	6.8%
272	Lymphatic Metastasis	6.7%
273	Neoplasms, Unknown Primary	6.7%
274	Leukemic Infiltration	6.7%
275	Breast Neoplasms, Male	6.7%
276	Neoplasm Micrometastasis	6.7%
277	Triple Negative Breast Neoplasms	6.7%
278	Thyroid Nodule	6.7%
279	Denys-Drash Syndrome	6.3%
280	Esophageal Neoplasms	6.1%
281	Limbic Encephalitis	6.1%
282	Meningeal Neoplasms	5.6%
283	Choledochal Cyst	5.6%
284	Peutz-Jeghers Syndrome	5.4%
285	Lambert-Eaton Myasthenic Syndrome	5.3%
286	Testicular Neoplasms	5.3%
287	Adrenal Gland Neoplasms	5.3%
288	Gastrointestinal Neoplasms	5.3%
289	Genital Neoplasms, Male	5.3%
290	Liver neoplasms	5.3%
291	Uveal Neoplasms	5.3%
292	Urologic Neoplasms	5.2%
293	Sebaceous Gland Neoplasms	5.1%
294	Spinal Neoplasms	5.1%
295	Bone Marrow Neoplasms	5.1%
296	Meningeal Carcinomatosis	5%
297	Polycystic Ovary Syndrome	5%
298	Opsoclonus-Myoclonus Syndrome	4.6%
299	Palatal Neoplasms	4.5%
300	Ear Neoplasms	4.3%
301	Eyelid Neoplasms	4.3%
302	Lung Neoplasms	4.3%
303	Pleural Neoplasms	4.3%
304	Nose Neoplasms	4.3%
305	Cell Transformation, Viral	4.2%
306	Brain Neoplasms	4.2%
307	Salivary Gland Neoplasms	4.2%
308	Spinal Cord Neoplasms	4.2%
309	Tongue Neoplasms	4.2%
310	Uterine Neoplasms	4.1%
311	Vaginal Neoplasms	4.1%
312	Vulvar Neoplasms	4.1%
313	Uterine Cancer	4.1%
314	Fallopian Tube Neoplasms	4.1%
315	Hydatidiform Mole	4.1%
316	Myelitis, Transverse	4%
317	Bronchial Neoplasms	3.8%
318	Multiple Pulmonary Nodules	3.8%
319	Pituitary Adenoma	3.7%
320	Pituitary Neoplasms	3.7%
321	Supratentorial Neoplasms	3.7%
322	Endometrial Neoplasms	3.7%
323	Pharyngeal Neoplasms	3.5%
324	Brain Stem Neoplasms	3.5%
325	Central Nervous System Cysts	3.4%
326	ovarian neoplasm	3.4%
327	Bile Duct Neoplasms	3.4%
328	gallbladder neoplasm	3.4%
329	Intestinal Neoplasms	3.4%
330	Penile Neoplasms	3.4%
331	Prostatic Neoplasms	3.4%
332	Stomach Neoplasms	3.4%
333	Choroid Plexus Papilloma	3.3%
334	Polycythemia Vera	3.3%
335	Hypopharyngeal Neoplasms	3%
336	Pleural Effusion, Malignant	3%
337	Hypopharyngeal Cancer	3%
338	Xeroderma Pigmentosum	3%
339	Parotid Neoplasms	3%
340	Prostatic Neoplasms, Castration-Resistant	3%
341	Nelson Syndrome	2.9%
342	Laryngeal neoplasm	2.9%
343	Tonsillar Neoplasms	2.8%
344	Cerebellar Neoplasms	2.8%
345	Bladder Neoplasm	2.8%
346	Kidney Neoplasm	2.8%
347	Ureteral Neoplasms	2.8%
348	Urethral Neoplasms	2.8%
349	Zollinger-Ellison syndrome	2.5%
350	Cecal Neoplasms	2.5%
351	Duodenal Neoplasms	2.5%
352	Radicular Cyst	2.3%
353	Appendiceal Neoplasms	2.3%
354	Colonic Neoplasms	2.3%
355	Rectal Neoplasms	2.3%
356	Nasopharyngeal Neoplasms	2.1%
357	Colorectal Neoplasms	2.1%
358	Anus Neoplasms	1.9%
359	Sigmoid Neoplasms	1.9%
360	Paranasal Sinus Neoplasms	1.9%
361	Maxillary Sinus Neoplasms	1.7%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234